News

06Nov

Press Release: Abacus dx Announces Partnership with Response Biomedical

Abacus dx Announces Commercial Partnership with Response Biomedical in Australia & New Zealand’s Clinical Market Sector

Brisbane, 6th November 2024

biochemistry, d-dimer, myoglobin, NT-ProBNP, RAMP, response biomedical

06Nov

Response Biomedical – RAMP 200

The RAMP^® 200 by Response Biomedical is a cutting-edge point-of-care device designed to streamline acute care diagnostic testing.

Acute care IVD, AMI, biochemistry, Cardiac disease, Cardiac markers, d-dimer, DVT, myoglobin, NT-ProBNP, POCT

Top